Anti-CD70 [BU69] mAb

Cat. #151436

Anti-CD70 [BU69] mAb

Cat. #: 151436

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD70

Class: Monoclonal

Application: FACS ; IHC ; IP

Reactivity: Human

Host: Mouse


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Roy Jefferis

Institute: University of Birmingham

Tool Details
Target Details

Tool Details


  • Name: Anti-CD70 [BU69] mAb
  • Alternate name: CD7 Molecule; Tumor Necrosis Factor Ligand Superfamily Member 7; CD27 Ligand; CD27LG; TNFSF7; CD27L; Tumor Necrosis Factor Ligand 8A; Surface Antigen CD7; Ki-24 Antigen; CD7 Antigen; TNLG8A
  • Clone: BU69
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 30 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IP
  • Description: BU69 inhibits T cell proliferation induced by dendritic cells.
  • Immunogen: Waldenstroms macroglobulineamia cell line WM-1
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1
  • Recommended controls: Raji cells

Target Details

  • Target: CD70
  • Molecular weight: 30 kDa
  • Tissue cell line specificity: Raji cells
  • Target background: CD70 is a 30kDa ligand of the receptor CD27. Both belong to the tumour necrosis factor receptor superfamily 7. Receptor activation can induce proliferation and apoptosis.


  • Application: FACS ; IHC ; IP


  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C


  • Schlossman, S.F. et al. 1995 Leukocyte Typing V Oxford University Press
  • Ito et al. 1999. J Immunol. 163(3):1409-19. PMID: 10415041.
  • A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells.